CG Oncology Revenue

In the year 2025, CG Oncology had annual revenue of $4.04M with 254.70% growth. CG Oncology had revenue of $2.32M in the quarter ending December 31, 2025, with 409.21% growth.

Revenue (ttm)

$4.04M

Revenue Growth

+254.70%

P/S Ratio

1,459.02

Revenue / Employee

$28,451

Employees

142

Market Cap

5.77B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	4.04M	2.90M	254.70%
Dec 31, 2024	1.14M	935.00K	458.33%
Dec 31, 2023	204.00K	13.00K	6.81%
Dec 31, 2022	191.00K	-10.17M	-98.16%
Dec 31, 2021	10.36M	-	-

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
PTC Therapeutics	1.73B
Caris Life Sciences	812.03M
Mirum Pharmaceuticals	521.31M
Rhythm Pharmaceuticals	189.76M
Centessa Pharmaceuticals	15.00M
Xenon Pharmaceuticals	7.50M

Revenue Rankings

CGON News

5 weeks ago - CG Oncology Reports 2025 Year End Financial Results and Provides Business Updates - GlobeNewsWire
6 weeks ago - CG Oncology to Present at the TD Cowen 46th Annual Health Care Conference - GlobeNewsWire
3 months ago - CG Oncology Provides Updated Timeline for PIVOT-006 Phase 3 Topline Data in Intermediate-Risk NMIBC - GlobeNewsWire
3 months ago - CG Oncology to Present at the 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
4 months ago - New Cretostimogene Grenadenorepvec Data Highlight its Potential to Become the Backbone Therapy for High-Risk Non-Muscle Invasive Bladder Cancer - GlobeNewsWire
4 months ago - CG Oncology Announces New Board Member and Board Transition - GlobeNewsWire
5 months ago - CG Oncology Reports Third Quarter 2025 Financial Results and Provides Business Updates - GlobeNewsWire
7 months ago - CG Oncology Stock Signals Bullish Momentum Ahead - Benzinga

More News